Kezar Life Sciences Ownership | Who Owns Kezar Life Sciences?

Kezar Life Sciences Ownership Summary

Kezar Life Sciences is owned by 5.16% institutional investors, 14.80% insiders, and 80.04% retail investors. Suvretta capital management is the largest institutional shareholder, holding 9.85% of KZR shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 10.48% of its assets in Kezar Life Sciences shares.

KZR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Kezar Life Sciences	5.16%	14.80%	80.04%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	7.17M	9.85%	$4.30M
Avidity partners management lp	5.03M	6.90%	$3.02M
Vanguard group	2.74M	3.77%	$1.64M
Sphera funds management	2.05M	2.82%	$1.23M
Orbimed advisors	1.93M	2.65%	$1.16M
Acadian asset management	1.86M	2.55%	$1.11M
Affinity asset advisors	1.76M	2.42%	$1.06M
Two sigma advisers, lp	1.24M	1.70%	$742.56K
Two sigma investments, lp	1.15M	1.58%	$688.91K
Stonepine capital management	1.05M	1.44%	$630.27K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Qiming u.s. ventures management	828.71K	0.94%	$497.23K
Stonepine capital management	1.05M	0.57%	$630.27K
Acuitas investments	986.78K	0.32%	$592.07K
Sphera funds management	2.05M	0.17%	$1.23M
Suvretta capital management	7.17M	0.16%	$4.30M
Avidity partners management lp	5.03M	0.13%	$3.02M
Affinity asset advisors	1.76M	0.12%	$1.06M
Ikarian capital	868.99K	0.09%	$521.39K
Orbimed advisors	1.93M	0.02%	$1.16M
Marquette asset management	178.06K	0.02%	$106.83K

Top Buyers

Holder	Shares	% Assets	Change
Stonepine capital management	1.05M	0.57%	1.05M
Goldman sachs group	1.02M	0.00%	614.47K
Jane street group	549.06K	0.00%	524.49K
Acuitas investments	986.78K	0.32%	295.96K
Rbf capital	282.52K	0.01%	282.52K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	830.37K	-	-3.79M
Adar1 capital management	-	-	-1.09M
State street	185.94K	-	-937.83K
Geode capital management	545.23K	-	-828.46K
Tang capital management	-	-	-688.94K

New Positions

Holder	Shares	% Assets	Change	Value
Stonepine capital management	1.05M	0.57%	1.05M	$630.27K
Rbf capital	282.52K	0.01%	282.52K	$169.51K
Point72 asia (singapore) pte.	105.11K	0.01%	105.11K	$63.06K
Mackenzie financial	58.71K	0.00%	58.71K	$35.23K
Global retirement partners	10.00K	0.00%	10.00K	$6.00K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-13.00
Nisa investment advisors	-50.00
Capital advisors	-1.61K
Amalgamated bank	-1.63K
Ameritas investment partners	-4.13K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	58	-25.64%	37,658,818	-4.33%	5	0.18%	18	-52.63%	22	-4.35%
Jun 30, 2024	78	-9.30%	39,364,790	-12.05%	54	1.42%	38	-	23	-17.86%
Mar 31, 2024	86	2.38%	44,760,196	-9.36%	61	1.34%	38	-5.00%	28	7.69%
Dec 31, 2023	84	-5.62%	49,383,993	-10.99%	67	1.16%	40	2.56%	26	-18.75%
Sep 30, 2023	89	-20.54%	55,483,503	-2.43%	76	1.24%	39	-27.78%	32	-3.03%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	764.73K	10.48%	-
Fidelity Extended Market Index	366.37K	5.02%	72.61K
International Biotechnology Ord	350.39K	4.80%	-
Biotech Growth Ord	1.93M	2.64%	1.93M
Vanguard Total Stock Mkt Idx Inv	187.76K	2.57%	-
Fidelity Total Market Index	86.44K	1.18%	-
Fidelity Series Total Market Index	85.22K	1.17%	7.89K
SG Actions US Techno C	82.24K	1.13%	-
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc	693.06K	0.95%	-100.25K
Vifag 2002 SICAV	45.00K	0.62%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 02, 2024	Schiller Mark C.	Chief Legal Officer	Sell	$3.88K
Feb 06, 2023	Morningside Venture Investments Ltd	-	Sell	$275.32K
Feb 03, 2023	Morningside Venture Investments Ltd	-	Sell	$178.65K
Feb 02, 2023	Morningside Venture Investments Ltd	-	Sell	$359.50K
Feb 01, 2023	Morningside Venture Investments Ltd	-	Sell	$278.00K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-
2023 Q2	-	-

KZR Ownership FAQ

Who Owns Kezar Life Sciences?

Kezar Life Sciences shareholders are primarily institutional investors at 5.16%, followed by 14.80% insiders and 80.04% retail investors. The average institutional ownership in Kezar Life Sciences's industry, Biotech Stocks , is 44.97%, which Kezar Life Sciences falls below.

Who owns the most shares of Kezar Life Sciences?

Kezar Life Sciences’s largest shareholders are Suvretta capital management (7.17M shares, 9.85%), Avidity partners management lp (5.03M shares, 6.90%), and Vanguard group (2.74M shares, 3.77%). Together, they hold 20.51% of Kezar Life Sciences’s total shares outstanding.

Does Blackrock own Kezar Life Sciences?

BlackRock is not among the top 10 institutional shareholders of Kezar Life Sciences.

Who is Kezar Life Sciences’s biggest shareholder by percentage of total assets invested?

Qiming u.s. ventures management is Kezar Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.94% of its assets in 828.71K Kezar Life Sciences shares, valued at 497.23K$.

Who is the top mutual fund holder of Kezar Life Sciences shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Kezar Life Sciences shares, with 10.48% of its total shares outstanding invested in 764.73K Kezar Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools